VAFP
MRNA icon

Vahanian & Associates Financial Planning’s Moderna MRNA Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,901
Closed -$483K – 119
2021
Q4 		$483K Buy
+1,901
New +$556K 0.39% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vahanian & Associates Financial Planning's MRNA Position: Q1 2022 in Review

Vahanian & Associates Financial Planning sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,901 shares — an estimated $483K sold.

Vahanian & Associates Financial Planning first reported a position in MRNA in Q4 2021 and held it in 1 quarter. The position peaked at $483K in Q4 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Vahanian & Associates Financial Planning reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Vahanian & Associates Financial Planning sold 1,901 Moderna shares in Q1 2022, an estimated $483K.
  • Vahanian & Associates Financial Planning first reported a position in Moderna in Q4 2021 and held it in 1 quarter.
  • Vahanian & Associates Financial Planning's Moderna position peaked at $483K in Q4 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Vahanian & Associates Financial Planning's 13F filing for Q1 2022, filed 27 Apr 2022.